Leading pain relief brand Nurofen has launched ‘See My Pain’, a new brand platform, that highlights how women’s pain has been overlooked, ignored and dismissed for far too long. As part of the campaign Nurofen has released its first Gender Pain Gap Index Report, which explores how gender pain bias affects women’s lived experiences.
The campaign kicks off today with the launch of the Nurofen Gender Pain Gap Index Report which reveals the true extent of the gender pain bias that women experience every day, where women are not taken seriously or deemed ‘emotional’ when it comes to their pain. The campaign rolls out across earned, owned and paid media across the UK.
Dr Angela Naef, Chief Research and Development Officer at Nurofen parent company Reckitt shares: “There is a Gender Pain Gap that afflicts the lives of so many women. Our mission is to help close this gap. As an initial step, we are proud to introduce the very first Nurofen Gender Pain Gap Index Report, which provides a suite of evidence on the extent of the gap between women and men’s experience and treatment of pain. The report is based on a nationwide survey of over 5,000 UK respondents, both women and men. These insights create a starting point for change and will help us measure our progress in closing that gap over time.”